ASCO: Promising Start to Pediatric MATCH Trial

Approximately 25% of patients with tumor samples submitted to the Pediatric MATCH program have been matched to an investigational therapy at an interim analysis reported ahead of the ASCO Annual Meeting.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news